CAP/IASLC/AMP Molecular Testing Guideline

CAP/IASLC/AMP Molecular Testing Guideline

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors - 2018

Lung Cancer Guideline Infographic

 

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) have updated and revised their 2013 evidence-based "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors". "The "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors" continues to set evidence-based standards for clinical molecular testing of non-small cell lung cancers (NSCLC) that effectively guides targeted therapy and treatment.

Project Co-Chairs:

Philip T. Cagle, MD on behalf of CAP

Yasushi Yatabe, MD, PhD on behalf of IASLC

Neal Lindeman, MD on behalf of AMP

The IASLC offers the following resources:

Full Article from the JTO

Lung Cancer Guideline Press Release

Summary of Recommendations

Key Messages

Teaching Slide Set

Infographic

Video for Physicians

Video for Patients

Lung Cancer Guideline FAQ

Molecular Testing Guideline for the Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors - 2013

 

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) have developed an evidence-based guideline, “Molecular Testing Guideline for the Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors,” which establishes standards for EGFR and ALK testing, helping to guide targeted therapies. The guideline was released on April 3, 2013, in Archives of Pathology & Laboratory Medicine, the Journal of Thoracic Oncology, and the Journal of Molecular Diagnostics.

The IASLC offers the following resources:

View the Full article on the JTO Website

Download a Summary of the Recommendations

View the Patient Guide

View the Slide deck of the webcast

View the Webcast with the lead authors of the guideline 

View the Videos about the guideline